Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Smith Insider Profile
4 Followers
Mark Smith, Director at Australian Pharmaceutical Industries Ltd, holds 415.00K shares in Australian Pharmaceutical Industries Ltd (Ticker: AU:API). Most recently, Mark Smith Bought AU$40,000 shares of Australian Pharmaceutical Industries Ltd on Apr 24, 2020 for an estimated value of 41.55K.
Mark Smith Australian Pharmaceutical Industries Ltd (API)Director
Australian Pharmaceutical Industries Ltd (API)
Director
Ranked #38,329 out of 99,335 Corporate Insiders
Profitable Transactions
9 out of 15 Profitable Transactions
Average Return
+0.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Mark Smith does not currently own shares as a corporate insider.
A breakdown of Mark Smith's holdings
Insider Roles
Mark Smith does not currently hold a role as a corporate insider.
Roles that Mark Smith holds in companies
Most Profitable Insider Trade
Stock:
Australian Pharmaceutical Industries Ltd
(API)
(API)
Rating:Informative Buy
Date:Apr 24, 2020 - Apr 24, 2021
Return:+24.90%
The most profitable trade made by Mark Smith
Mark Smith's Trading History
List of latest transactions for each holding click on a transaction to see Mark Smith's performance on stock
You May Also Like
Mark Smith insider profile FAQ
What is the percentage of profitable transactions made by Mark Smith?
The percentage of profitable transactions made by Mark Smith is 60%.
What is the average return per transaction made by Mark Smith?
The average return per transaction made by Mark Smith is 0.80%.
What stocks does Mark Smith hold?
Mark Smith holds: AU:API stocks.
What was Mark Smith’s latest transaction?
Mark Smith latest transaction was an Informative Buy of AU$41.55K.
What was Mark Smith's most profitable transaction?
Mark Smith’s most profitable transaction was an Informative Buy of AU:API stock on April 24, 2020. The return on the trade was 24.90%.
What is Mark Smith's role in Australian Pharmaceutical Industries Ltd?
Mark Smith's role in Australian Pharmaceutical Industries Ltd is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.